Company intelligence / Profile preview

Vatera Healthcare Partners

New York City, New York, United Statesinstantcheckmate.com ↗

Ownership: Private
Employees: ~20
Development stage: Phase 3

Overview

Vatera Healthcare Partners is a New York-based venture capital and private equity firm established in 2007 by Michael Jaharis. It focuses on investing in life science and biopharmaceutical firms at various stages. The firm has backed notable companies such as Melinta Therapeutics and ImmusanT. It remains active with ongoing investments primarily within the United States.

Therapeutic areas: OncologyGastroenterologyInfectious Diseases
Modalities: Small moleculeBiologic therapies
Industry: Investors

Drug pipeline

1 asset

formoterol fumarate + glycopyrrolate

Phase 3

Indications: Chronic obstructive pulmonary disease

Partnerships

Co-investments with New Leaf Venture PartnersClarus Ventures5AM Ventures

Beyond the preview

Go deeper on Vatera Healthcare Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vatera Healthcare Partners.

Explore the full profile